Relmada Therapeutics, Inc. (RLMD)
5.91
-0.24
(-3.90%)
USD |
NASDAQ |
Mar 13, 16:00
5.90
-0.01
(-0.17%)
After-Hours: 20:00
Relmada Therapeutics Total Assets (Quarterly) : 14.88M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 949.87M |
| Invivyd, Inc. | 276.88M |
| Arcellx, Inc. | 603.99M |
| AN2 Therapeutics, Inc. | 67.24M |
| ACADIA Pharmaceuticals, Inc. | 1.564B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.411M |
| Shareholders Equity (Quarterly) | 9.466M |
| Current Ratio | 2.862 |